Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% GGA 6.30 +2.4% PRG 0.260 −3.7% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% GGA 6.30 +2.4% PRG 0.260 −3.7%

Healthcare

Page 73
  1. Jan 19, 2026 · 04:02 · 4565

    Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

    Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

    01
  2. Jan 19, 2026 · 03:05 · BNXT

    BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF

    BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF

    02
  3. Jan 16, 2026 · 21:02 · AIDR

    Rocket Doctor AI increases private placement to $4.5M

    Rocket Doctor AI increases private placement to $4.5M

    03
  4. Jan 16, 2026 · 18:36 · NGMD

    Nugen looks back at 2025 R&D programs

    Nugen looks back at 2025 R&D programs

    04
  5. Jan 16, 2026 · 17:31 · NGMD

    NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

    NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

    05
  6. Jan 16, 2026 · 16:06 · HEM

    Hemostemix gets FDA support for basket protocol

    Hemostemix gets FDA support for basket protocol

    06
  7. Jan 16, 2026 · 15:22 · CRDL

    Cardiol Therapeutics arranges $13.5-million bought deal

    Cardiol Therapeutics arranges $13.5-million bought deal

    07
  8. Jan 16, 2026 · 12:27 · HEM

    Hemostemix Receives FDA Support for Its Basket Protocol Approach

    Hemostemix Receives FDA Support for Its Basket Protocol Approach

    08
  9. Jan 16, 2026 · 12:06 · FNDX

    Canadian Securities Exchange Reports Strong 2025 Performance Figures

    Canadian Securities Exchange Reports Strong 2025 Performance Figures

    09
  10. Jan 16, 2026 · 11:40 · VPT

    AI Diagnostics: The End of the High-Cost Imaging Era

    AI Diagnostics: The End of the High-Cost Imaging Era

    10
  11. Jan 16, 2026 · 08:42 · CRDL

    Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

    Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

    11
  12. Jan 16, 2026 · 08:00 · EXE

    Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call

    Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call

    12
  13. Jan 16, 2026 · 02:32 · NURS

    Hydreight arranges $10-million bought deal offering

    Hydreight arranges $10-million bought deal offering

    13
  14. Jan 15, 2026 · 19:14 · BUX

    Biomark research to be published in Frontiers

    Biomark research to be published in Frontiers

    14
← Newer Older →